<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Midazolam and etomidate have been shown to depress cerebral metabolism and may protect the brain during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, it has been reported that etomidate may produce EEG spiking activity and <z:hpo ids='HP_0001250'>seizures</z:hpo>, which could adversely affect outcome </plain></SENT>
<SENT sid="2" pm="."><plain>We compared the effects of midazolam and etomidate on EEG, cerebral blood flow (CBF), and cerebral cortical oxygen consumption (CMRO2) as well as neurologic outcome following incomplete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the rat </plain></SENT>
<SENT sid="3" pm="."><plain>CBF was measured with radioactive microspheres and cortical CMRO2 was calculated by multiplying cortical CBF by the arterial-sagittal sinus oxygen content </plain></SENT>
<SENT sid="4" pm="."><plain>Incomplete <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was produced by unilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In low doses (0.02 mg/kg/min i.v.), both midazolam and etomidate depressed EEG, decreased CMRO2, and improved outcome from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> compared to nitrous <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> control rats </plain></SENT>
<SENT sid="6" pm="."><plain>At a higher dose (0.2 mg/kg/min i.v.), midazolam further depressed EEG and CMRO2 and again improved outcome compared to <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> controls </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, high dose etomidate (0.2 mg/kg/min) produced spiking EEG activity without further <z:hpo ids='HP_0000716'>depression</z:hpo> of CMRO2 and a worsening of outcome following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These results support previous reports that midazolam and etomidate may protect the brain from incomplete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> but suggest that EEG spiking activity associated with high dose etomidate may be associated with a worse outcome </plain></SENT>
</text></document>